Skip to main content
Erschienen in: Neuroradiology 1/2019

28.11.2018 | Interventional Neuroradiology

Submaximal primary angioplasty for symptomatic intracranial atherosclerosis: peri-procedural complications and long-term outcomes

verfasst von: Guangge Peng, Jingyu Zhang, Baixue Jia, Ziqi Xu, Dapeng Mo, Ning Ma, Feng Gao, Zhongrong Miao

Erschienen in: Neuroradiology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The aim of our study is to report the peri-procedural complications and long-term stroke recurrent rate of symptomatic intracranial atherosclerosis (ICAS) patients who underwent submaximal primary angioplasty.

Methods

This is a retrospective analysis of consecutive patients in a single center who underwent submaximal primary angioplasty between January 1, 2012 and December 31, 2015. The peri-procedural complications and long-term outcomes are reported.

Results

Primary angioplasty was successfully performed in 129 patients (97.0%). The mean degree of pre-procedural stenosis was 81.9 ± 10.2%, and the degree of residual stenosis was 40.7 ± 19.1%. There were nine (6.8%) peri-procedural complications within 30 days, including seven ischemic strokes, one subarachnoid hemorrhage, and one asymptomatic intracerebral hemorrhage. None of them resulted in death. One-year follow-up was available in 122 patients (91.7%). Three more ischemic strokes (2.3%) which were in the territory of the treated artery occurred between 30 days and 1 year. The 1-year stroke and death rate was 9.0%, including peri-procedural stroke. Kaplan-Meier analysis showed a 3-year stroke-free survival of 87.2%.

Conclusion

Submaximal primary angioplasty can be performed with a low peri-procedural complication rate and relatively good clinical outcome at long-term follow-up for symptomatic ICAS patients.
Literatur
5.
Zurück zum Zitat Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, Levy EI (2012) Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery 71(6):1103–1110. https://doi.org/10.1227/NEU.0b013e318271bcb8 CrossRefPubMed Dumont TM, Kan P, Snyder KV, Hopkins LN, Siddiqui AH, Levy EI (2012) Revisiting angioplasty without stenting for symptomatic intracranial atherosclerotic stenosis after the stenting and aggressive medical management for preventing recurrent stroke in intracranial stenosis (SAMMPRIS) study. Neurosurgery 71(6):1103–1110. https://​doi.​org/​10.​1227/​NEU.​0b013e318271bcb8​ CrossRefPubMed
17.
Zurück zum Zitat Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21(4):643–646PubMed Samuels OB, Joseph GJ, Lynn MJ, Smith HA, Chimowitz MI (2000) A standardized method for measuring intracranial arterial stenosis. AJNR Am J Neuroradiol 21(4):643–646PubMed
19.
Zurück zum Zitat Villwock MR, Padalino DJ, Ramaswamy R, Deshaies EM (2016) Primary angioplasty versus stenting for endovascular management of intracranial atherosclerotic disease following acute ischemic stroke. J Vasc Interv Neurol 9(1):1–6PubMedPubMedCentral Villwock MR, Padalino DJ, Ramaswamy R, Deshaies EM (2016) Primary angioplasty versus stenting for endovascular management of intracranial atherosclerotic disease following acute ischemic stroke. J Vasc Interv Neurol 9(1):1–6PubMedPubMedCentral
Metadaten
Titel
Submaximal primary angioplasty for symptomatic intracranial atherosclerosis: peri-procedural complications and long-term outcomes
verfasst von
Guangge Peng
Jingyu Zhang
Baixue Jia
Ziqi Xu
Dapeng Mo
Ning Ma
Feng Gao
Zhongrong Miao
Publikationsdatum
28.11.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Neuroradiology / Ausgabe 1/2019
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-018-2133-y

Weitere Artikel der Ausgabe 1/2019

Neuroradiology 1/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.